ClearPoint Neuro (CLPT) Competitors $10.54 -0.56 (-5.00%) Closing price 03:59 PM EasternExtended Trading$10.81 +0.28 (+2.61%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLPT vs. MDXG, PLSE, INMD, IRMD, EMBC, TNDM, KMTS, BBNX, AXGN, and SIBNShould you be buying ClearPoint Neuro stock or one of its competitors? The main competitors of ClearPoint Neuro include MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), iRadimed (IRMD), Embecta (EMBC), Tandem Diabetes Care (TNDM), Kestra Medical Technologies (KMTS), Beta Bionics (BBNX), AxoGen (AXGN), and SiBone (SIBN). These companies are all part of the "medical equipment" industry. ClearPoint Neuro vs. Its Competitors MiMedx Group Pulse Biosciences InMode iRadimed Embecta Tandem Diabetes Care Kestra Medical Technologies Beta Bionics AxoGen SiBone ClearPoint Neuro (NASDAQ:CLPT) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk. Which has more risk and volatility, CLPT or MDXG? ClearPoint Neuro has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.74, indicating that its share price is 74% more volatile than the S&P 500. Does the media refer more to CLPT or MDXG? In the previous week, ClearPoint Neuro had 1 more articles in the media than MiMedx Group. MarketBeat recorded 2 mentions for ClearPoint Neuro and 1 mentions for MiMedx Group. MiMedx Group's average media sentiment score of 1.79 beat ClearPoint Neuro's score of 0.63 indicating that MiMedx Group is being referred to more favorably in the news media. Company Overall Sentiment ClearPoint Neuro Positive MiMedx Group Very Positive Do analysts rate CLPT or MDXG? ClearPoint Neuro presently has a consensus price target of $19.67, indicating a potential upside of 86.68%. MiMedx Group has a consensus price target of $12.00, indicating a potential upside of 72.84%. Given ClearPoint Neuro's higher probable upside, analysts clearly believe ClearPoint Neuro is more favorable than MiMedx Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ClearPoint Neuro 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, CLPT or MDXG? MiMedx Group has higher revenue and earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearPoint Neuro$31.39M9.54-$18.91M-$0.81-13.01MiMedx Group$348.88M2.94$42.42M$0.2133.06 Is CLPT or MDXG more profitable? MiMedx Group has a net margin of 8.84% compared to ClearPoint Neuro's net margin of -66.15%. MiMedx Group's return on equity of 23.03% beat ClearPoint Neuro's return on equity.Company Net Margins Return on Equity Return on Assets ClearPoint Neuro-66.15% -94.44% -51.58% MiMedx Group 8.84%23.03%17.09% Do institutionals & insiders believe in CLPT or MDXG? 30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 79.2% of MiMedx Group shares are held by institutional investors. 7.0% of ClearPoint Neuro shares are held by company insiders. Comparatively, 1.7% of MiMedx Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryMiMedx Group beats ClearPoint Neuro on 10 of the 15 factors compared between the two stocks. Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLPT vs. The Competition Export to ExcelMetricClearPoint NeuroMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$299.51M$6.79B$5.81B$10.16BDividend YieldN/A1.23%5.69%4.60%P/E Ratio-13.0126.0374.6225.97Price / Sales9.5462.88454.4485.61Price / CashN/A21.6337.0859.91Price / Book11.455.0012.156.29Net Income-$18.91M$176.38M$3.28B$270.77M7 Day Performance-4.66%1.00%0.98%3.32%1 Month Performance-0.05%3.18%7.19%6.40%1 Year Performance-13.51%12.36%63.14%28.24% ClearPoint Neuro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLPTClearPoint Neuro1.9353 of 5 stars$10.54-5.0%$19.67+86.7%-9.2%$299.51M$31.39M-13.01110MDXGMiMedx Group3.4983 of 5 stars$7.10-1.1%$12.00+69.0%+15.3%$1.05B$348.88M33.81870Positive NewsPLSEPulse Biosciences4.1347 of 5 stars$15.54-0.1%$22.00+41.6%-11.9%$1.05B$700K-14.80140Positive NewsINMDInMode3.0559 of 5 stars$14.94+0.1%$18.04+20.8%-9.2%$944.34M$394.82M6.05480Positive NewsIRMDiRadimed4.8063 of 5 stars$72.44-0.8%$72.00-0.6%+58.9%$921.44M$73.24M44.72110Positive NewsShort Interest ↓EMBCEmbecta4.5122 of 5 stars$14.48-0.1%$19.00+31.2%-1.7%$846.86M$1.12B10.132,100Positive NewsTNDMTandem Diabetes Care4.4939 of 5 stars$12.51+6.1%$22.47+79.6%-70.1%$845.29M$940.20M-4.052,650Positive NewsKMTSKestra Medical Technologies1.609 of 5 stars$16.14-8.9%$27.33+69.4%N/A$828.77M$59.81M0.00300News CoveragePositive NewsGap UpBBNXBeta Bionics1.0921 of 5 stars$18.84+0.7%$22.56+19.7%N/A$818.98M$65.12M0.00294AXGNAxoGen2.8944 of 5 stars$16.14-0.5%$26.00+61.1%+26.5%$742.64M$187.34M-161.38450Positive NewsSIBNSiBone3.7856 of 5 stars$16.67+0.3%$23.67+42.0%+8.2%$719.16M$167.18M-29.77350Positive News Related Companies and Tools Related Companies MiMedx Group Competitors Pulse Biosciences Competitors InMode Competitors iRadimed Competitors Embecta Competitors Tandem Diabetes Care Competitors Kestra Medical Technologies Competitors Beta Bionics Competitors AxoGen Competitors SiBone Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLPT) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLPT Stock Alerts